Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paula Boutin
Observed names:
P. Boutin,
Paula M. BOUTIN,
Paula M. Boutin
Institution:
Sanofi (United States)
Observed institutions:
Brigham and Women's Hospital,
Van Andel Institute,
Harvard University,
National University of Mar del Plata,
Kirin (Japan),
Sanofi (United States),
Kirin (United States)
show all 7
OpenAlex ID:
A5001462326
Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis
2012
·
Sambasiva P. Rao
, Jose Sancho
, et al.
·
PLoS ONE
·
191
PDF
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization
2008
·
Rebecca G. Bagley
, Nakayuki Honma
, et al.
·
Microvascular Research
·
125
Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models
2010
·
William M. Siders
, Jacqueline Shields
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
82
Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function
2006
·
Cecile Rouleau
, Andre Roy
, et al.
·
Molecular Cancer Therapeutics
·
66
PDF
Identification of a Binding Partner for the Endothelial Cell Surface Proteins TEM7 and TEM7R
2004
·
Akash Nanda
, Phillip Buckhaults
, et al.
·
Cancer Research
·
66
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248
2008
·
Rebecca G. Bagley
, Cecile Rouleau
, et al.
·
Molecular Cancer Therapeutics
·
56
Interactions between the Amino- and Carboxyl-Terminal Regions of G.alpha. Subunits: Analysis of Mutated G.alpha.o/G.alpha.i2 Chimeras
1995
·
Bradley M. Denker
, Paula M. Boutin
, et al.
·
Biochemistry
·
44
Tumor endothelial marker 7 (TEM-7): A novel target for antiangiogenic therapy
2011
·
Rebecca G. Bagley
, Cecile Rouleau
, et al.
·
Microvascular Research
·
28
Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients
2002
·
Franck Housseau
, Kimberly R Lindsey
, et al.
·
Journal of Immunological Methods
·
21
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: Assessment of receptor contribution
2008
·
Beverly Teicher
, Hans-Peter Biemann
, et al.
·
International Journal of Oncology
·
20
PDF
N-terminal binding domain of Gα subunits: involvement of amino acids 11–14 of Gα0 in membrane attachment
1997
·
Liliana BUSCONI
, Paula M. BOUTIN
, et al.
·
Biochemical Journal
·
14
Characterization of a Next Generation Anti-CD52 Antibody (S20.006)
2015
·
William Siders
, Ben Greene
, et al.
·
Neurology
·
1
Effects of anti-CD52 antibody treatment on immune cell depletion and progression of disease in murine systemic lupus erythematosus (119.13)
2012
·
Paula Boutin
, Peter Severy
, et al.
·
The Journal of Immunology
·
1
A droplet microfluidics-based platform for generating target-specific, natively-paired immune libraries and identifying potent and developable antibodies
2026
·
Anusuya Ramasubramanian
, Brendan T. Deveney
, et al.
·
Scientific Reports
PDF
Abstract 2445: Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models
2010
·
William M. Siders
, Jacqueline Shields
, et al.
·
Cancer Research
Investigation of the mechanism of action of Campath (Alemtuzumab)
2006
·
William Siders
, Jacqueline D. Shields
, et al.
·
Cancer Research
168 PRL-3 promotes invasion in tumor epithelial cells and tube formation in normal endothelial cells
2004
·
C. Rouleau
, L. Kurtzberg
, et al.
·
European Journal of Cancer Supplements
Anthrax toxin receptor (ANTXR1)/TEM 8 expression and sensitivity to protective antigen plus lethal factor.
2004
·
Cécile Rouleau
, Paula Boutin
, et al.
·
Cancer Research
Molecular cloning of Schistosoma mansoni allergens.
1987
·
Raymond J. Pierce
, François Trottein
, et al.
Show more works
View as search
Works count:
19
Citation count:
715
H-index:
11
I10-index:
11
Year
Topic
Type